Canada markets closed

Vaxcyte, Inc. (PCVX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.96+1.41 (+2.18%)
At close: 04:00PM EDT
65.96 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.17B
Enterprise Value 6.12B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.78
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -15.62

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 326.84%
S&P500 52-Week Change 322.38%
52 Week High 382.04
52 Week Low 344.20
50-Day Moving Average 367.16
200-Day Moving Average 357.91

Share Statistics

Avg Vol (3 month) 3727.75k
Avg Vol (10 day) 3769.65k
Shares Outstanding 5108.76M
Implied Shares Outstanding 6108.76M
Float 899.25M
% Held by Insiders 10.60%
% Held by Institutions 197.35%
Shares Short (Apr 15, 2024) 48.24M
Short Ratio (Apr 15, 2024) 412.65
Short % of Float (Apr 15, 2024) 48.78%
Short % of Shares Outstanding (Apr 15, 2024) 47.58%
Shares Short (prior month Mar 15, 2024) 48.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.24%
Return on Equity (ttm)-36.67%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -464.88M
Net Income Avi to Common (ttm)-402.27M
Diluted EPS (ttm)-4.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.08B
Total Cash Per Share (mrq)9.96
Total Debt (mrq)29.22M
Total Debt/Equity (mrq)2.36%
Current Ratio (mrq)7.54
Book Value Per Share (mrq)13.01

Cash Flow Statement

Operating Cash Flow (ttm)-296.79M
Levered Free Cash Flow (ttm)-202.41M